An ongoing dialogue on HIV/AIDS, infectious diseases,
March 3rd, 2010
Ritonavir Tablets: Any Experience Out There Yet?
Ritonavir tablets have been approved, and are apparently now in pharmacies. The capsules will also remain available for the foreseeable future.
However, I haven’t switched anyone over from the capsules yet, and neither has anyone else in our practice.
Would be interested in hearing how it’s going so far — best news would be that the tablets are both more convenient and have fewer side effects, but we know from the switch to Kaletra tablets that the latter might not occur.
(Which surprised me, I have to admit — thought the tablets would be better tolerated, but it was about the same.)
So … if you’ve switched patients to from the capsules to the tablets, comment away!
Categories: HIV, Patient Care
Tags: antiretroviral therapy, HIV, ritonavir
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
2 Responses to “Ritonavir Tablets: Any Experience Out There Yet?”
Paul E. Sax, MD
Contributing Editor
NEJM Journal Watch
Infectious Diseases
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
Follow HIV and ID Observations Posts via Email
- The Rise and Fall of Paxlovid
- Think Again Before Sending Your Patient Home on Intravenous Vancomycin
- Hey, Insurance Companies and Pharmacies — Stop Messing Around with the Price of Cheap Generic Drugs
- CROI 2024 Denver: Really Rapid Review
- Learning the Names of HIV Drugs Is Horribly Difficult — Here’s Why
- ID Cartoon Caption Contest (125)
- ID Cartoon Caption Contest #2 Winner — and a New Contest for the Holidays (92)
- Dear Nation — A Series of Apologies on COVID-19 (80)
- How to Induce Rage in a Doctor (77)
- IDSA’s COVID-19 Treatment Guidelines Highlight Difficulty of “Don’t Just Do Something, Stand There” (74)
-
NEJM Journal Watch — Recent Infectious Disease Articles
- How Well Do Public and Private Healthcare Providers Manage Chlamydia and Gonorrhea?
- Delivery of Malaria Vaccine Through National Immunization Programs: Achievable and Safe
- For Coordinating Management of Opioid Use Disorder and Hepatitis C Infection, Telemedicine Works
- Innovative Pairing of Beta-Lactamase Inhibitors to Combat Multidrug-Resistant Gram-Negative Pathogens
- Ceftobiprole Joins the Beta-Lactam Squad Against MRSA Infections
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease MRSA PEP Policy PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster
We have been using generic RTV tablet since 2-3 years in India and all the capsules have been withdrawn since then. The tolerance is good
Sanjay, thanks for the comment. I wonder how your generic ritonavir compares with the version now licensed in the USA.